Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1991 1
1992 13
1993 30
1994 38
1995 53
1996 79
1997 111
1998 180
1999 265
2000 380
2001 487
2002 697
2003 835
2004 1130
2005 1500
2006 1621
2007 1907
2008 2003
2009 2084
2010 2229
2011 2206
2012 2443
2013 2562
2014 2421
2015 2501
2016 2430
2017 2450
2018 2494
2019 2388
2020 1423
2021 2
Text availability
Article attribute
Article type
Publication date

Search Results

34,197 results
Results by year
Filters applied: . Clear all
Page 1
The cytokine storm of severe influenza and development of immunomodulatory therapy.
Liu Q, Zhou YH, Yang ZQ. Liu Q, et al. Cell Mol Immunol. 2016 Jan;13(1):3-10. doi: 10.1038/cmi.2015.74. Epub 2015 Jul 20. Cell Mol Immunol. 2016. PMID: 26189369 Free PMC article. Review.
We also review some of the current immunomodulatory strategies for the treatment of cytokine storms in severe influenza, including corticosteroids, peroxisome proliferator-activated receptor agonists, sphingosine-1-phosphate receptor 1 agonists, …
We also review some of the current immunomodulatory strategies for the treatment of cytokine storms in severe influenza, including corticost …
Peroxisome proliferator-activated receptor agonists and antagonists: a patent review (2014-present).
Takada I, Makishima M. Takada I, et al. Expert Opin Ther Pat. 2020 Jan;30(1):1-13. doi: 10.1080/13543776.2020.1703952. Epub 2019 Dec 18. Expert Opin Ther Pat. 2020. PMID: 31825687 Review.
Introduction: Peroxisome proliferator-activated receptors (PPARs), PPARα, PPARδ, and PPARγ, play an important role in the regulation of various physiological processes, specifically lipid and energy metabolism and immunity. ...
Introduction: Peroxisome proliferator-activated receptors (PPARs), PPARα, PPARδ, and PPARγ, play an important ro …
Peroxisome Proliferator-Activated Receptor Gamma Coactivator-1 Alpha as a Novel Target for Bipolar Disorder and Other Neuropsychiatric Disorders.
Nierenberg AA, Ghaznavi SA, Sande Mathias I, Ellard KK, Janos JA, Sylvia LG. Nierenberg AA, et al. Biol Psychiatry. 2018 May 1;83(9):761-769. doi: 10.1016/j.biopsych.2017.12.014. Epub 2018 Jan 10. Biol Psychiatry. 2018. PMID: 29502862 Review.
Peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC-1 alpha) is a protein that regulates metabolism and inflammation by activating nuclear receptors, especially the family of peroxisome proliferator-activat
Peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC-1 alpha) is a protein that regulates m
Self-regulation of the inflammatory response by peroxisome proliferator-activated receptors.
Korbecki J, Bobiński R, Dutka M. Korbecki J, et al. Inflamm Res. 2019 Jun;68(6):443-458. doi: 10.1007/s00011-019-01231-1. Epub 2019 Mar 29. Inflamm Res. 2019. PMID: 30927048 Free PMC article. Review.
The peroxisome proliferator-activated receptor (PPAR) family includes three transcription factors: PPARα, PPARβ/δ, and PPARγ. PPAR are nuclear receptors activated by oxidised and nitrated fatty acid derivatives as well as by cyclopentenon …
The peroxisome proliferator-activated receptor (PPAR) family includes three transcription factors: PPARα, PPARβ/ …
Astaxanthin as a Peroxisome Proliferator-Activated Receptor (PPAR) Modulator: Its Therapeutic Implications.
Choi CI. Choi CI. Mar Drugs. 2019 Apr 23;17(4):242. doi: 10.3390/md17040242. Mar Drugs. 2019. PMID: 31018521 Free PMC article. Review.
Peroxisome proliferator-activated receptors (PPARs) are part of the nuclear hormone receptors superfamily that plays a pivotal role in functions such as glucose and lipid homeostasis. ...
Peroxisome proliferator-activated receptors (PPARs) are part of the nuclear hormone receptors superfamily
Update on etiopathogenesis and treatment of Acne.
Bhat YJ, Latief I, Hassan I. Bhat YJ, et al. Indian J Dermatol Venereol Leprol. 2017 May-Jun;83(3):298-306. doi: 10.4103/0378-6323.199581. Indian J Dermatol Venereol Leprol. 2017. PMID: 28195079 Free article. Review.
Besides genetic predisposition, other major factors include the action of androgens, pro-inflammatory lipids acting as ligands of peroxisome proliferator-activated receptors in the sebocytes, toll-like receptor-2 acting on keratinocytes, recogni …
Besides genetic predisposition, other major factors include the action of androgens, pro-inflammatory lipids acting as ligands of peroxis
Cigarette Smoke Extract Modulates Functions of Peroxisome Proliferator-Activated Receptors.
Matsushita M, Futawaka K, Hayashi M, Murakami K, Mitsutani M, Hatai M, Watamoto Y, Yoshikawa N, Nakamura K, Tagami T, Moriyama K. Matsushita M, et al. Biol Pharm Bull. 2019;42(10):1628-1636. doi: 10.1248/bpb.b18-00991. Biol Pharm Bull. 2019. PMID: 31582651 Free article.
We examined the impact of CSE on transcriptional regulation mediated peroxisome proliferator-activated receptors (PPARs) and its interaction with cofactors to elucidate differences in the molecular mechanism between CSE and other agonists of PPARs. ... …
We examined the impact of CSE on transcriptional regulation mediated peroxisome proliferator-activated receptors
The Role of Peroxisome Proliferator-Activated Receptors and Their Transcriptional Coactivators Gene Variations in Human Trainability: A Systematic Review.
Petr M, Stastny P, Zajac A, Tufano JJ, Maciejewska-Skrendo A. Petr M, et al. Int J Mol Sci. 2018 May 15;19(5):1472. doi: 10.3390/ijms19051472. Int J Mol Sci. 2018. PMID: 29762540 Free PMC article. Review.
BACKGROUND: The peroxisome proliferator-activated receptors (PPARA, PPARG, PPARD) and their transcriptional coactivators' (PPARGC1A, PPARGC1B) gene polymorphisms have been associated with muscle morphology, oxygen uptake, power output and endurance per …
BACKGROUND: The peroxisome proliferator-activated receptors (PPARA, PPARG, PPARD) and their transcriptional coac …
Peroxisome Proliferator-Activated Receptor Ligands and Their Role in Chronic Myeloid Leukemia: Therapeutic Strategies.
Yousefi B, Samadi N, Baradaran B, Shafiei-Irannejad V, Zarghami N. Yousefi B, et al. Chem Biol Drug Des. 2016 Jul;88(1):17-25. doi: 10.1111/cbdd.12737. Epub 2016 Mar 6. Chem Biol Drug Des. 2016. PMID: 26841308 Review.
Furthermore, coupling imatinib with peroxisome proliferator-activated receptor ligands also showed beneficial effects in chronic myeloid leukemia cell proliferation. ...In this article, we reviewed the potential of peroxisome proliferator
Furthermore, coupling imatinib with peroxisome proliferator-activated receptor ligands also showed beneficial ef …
Current Progress on Peroxisome Proliferator-activated Receptor Gamma Agonist as an Emerging Therapeutic Approach for the Treatment of Alzheimer's Disease: An Update.
Khan MA, Alam Q, Haque A, Ashafaq M, Khan MJ, Ashraf GM, Ahmad M. Khan MA, et al. Curr Neuropharmacol. 2019;17(3):232-246. doi: 10.2174/1570159X16666180828100002. Curr Neuropharmacol. 2019. PMID: 30152284 Free PMC article. Review.
Peroxisome proliferatoractivated receptors (PPARs) are ligand-activated transcription factors known to play important role in the regulation of glucose absorption, homeostasis of lipid metabolism and are further known to involved in repressing the expression
Peroxisome proliferatoractivated receptors (PPARs) are ligand-activated transcription factors known to play important r
34,197 results
Jump to page
Feedback